Biochemistry presentations (MU)
Permanent URI for this collection
Items in this collection are the scholarly output of the Division of Biochemistry faculty, staff, and students, either alone or as co-authors, and which may or may not have been published in an alternate format. Items may contain more than one file type.
Browse
Recent Submissions
Item Scientists vs. journalists?: obligations, risks and benefits of communicating science to the public(2011) Beerman, Daniel; Allen, William, 1952-Scientists, for many reasons, aren't always the best communicators. Yet, communication skills are vital when informing the public about new research and scientific developments. This process involves scientists, the public and the media institutions through which they connect. The relationship between these groups is a subject of many studies and discussions.Item Maternal diet and sex of offspring(2006) Roberts, R. M. (Robert Michael), 1940-Powerpoint presentation delivered by Curators' Professor in the Department of Animal Science and Biochemistry in the College of Arts and Sciences at the University of Missouri-Columbia, R. Michael Roberts, as part of the Saturday Morning Science lecture series.Item How are drugs designed?(2009) Zou, XiaoqinAssistant Professor of Biochemistry at the University of Missouri-Columbia, Xiaoqin Zou, delivers a lecture on the history of medical drug production and uses.Item Porcine induced pluripotent stem cells (piPSC) for expanding the use of swine in biomedical research(2010-03) Ezashi, Toshihiko; Telugu, Bhanu Prakash V. L., 1977-; Roberts, R. M. (Robert Michael), 1940-; University of Missouri (System); Missouri Life Sciences Summit (2010: University of Missouri--Kansas City)Our goal is to create porcine pluripotent stem cells, i.e. ones capable of differentiating into all cell types of the body that can expand the use of swine as a biomedical model for studying human disease. It is well established that mouse embryonic stem cells (ESC) are an excellent source of material for successful cloning and for incorporation into chimeras. However, the establishment of porcine ESC from the embryos has proven to be elusive. There has been a similar lack of success with other ungulate species. Establishing a technology for deriving induced pluripotent stem cells (iPSC) from farm animals will allow the gene knock-in/knock-out methods that have revolutionized mouse genetics to be applied to farm species. Importantly pig is a potentially useful model for studying human pathologies due to similarities in organ size, immunology and whole animal physiology between the two species. If the safety and efficacy of stem cell transplantation is to be tested in an animal model before being applied to humans, the pig would likely be a species of choice. The ability to derive porcine (p) iPSC lines from a particular outbred animal and conduct tissue transplantation on the same pig later and follow the success of the transplant over the course of months or even years would be a particularly valuable advance. Additionally the ability to provide piPSC from animals with valuable traits would provide a permanent source of cells for clonal propagation that would likely avoid the inefficiencies and problems arising from somatic cell nuclear transfer (SCNT), where the vast majority of cloned offspring die or are developmentally abnormal. We have created piPSC from embryonic fibroblasts and umbilical cord mesenchyme by a similar strategy used for the mouse and human, namely ectopically expressing reprogramming genes in somatic cells. The piPSC resemble human ESC, express the typical gene and surface antigen markers of ESC, proliferate continuously in culture, possess high telomerase activity, form embryoid bodies, and differentiate along the three main germ line lineages. Our aim is to demonstrate that piPSC can be directed to differentiate along defined lineages, specifically towards neuronal tissue, hematopoietic lineages and various mesoderm derivatives including cardiomyocytes by using protocols based on those used successfully with human and murine ESC. These experiments will allow such cells to be used for tissue grafts that are matched genetically to recipients and tested for their safety in transplantation. We shall also establish parameters for routine gene targeting in piPSC, with the ultimate goal of creating genetic models for human diseases where mouse models are inappropriate. In summary, the piPSC lines developed will have enormous utility for exploiting the pig as a model in human pre-clinical applications. Supported by Missouri Life Sciences Board Grant 00022147 and NIH grant HD21896Item MU Translational Neuroscience Center: Progressing from Molecules to Behavior(2010) Miller, Dennis K. (Dennis Keith); Simonyi, Agnes; University of Missouri (System); Missouri Life Sciences Summit (2010: University of Missouri--Kansas City)An important component of modern neuroscience research is the ability to measure systematically and objectively different aspects of behavior. Behavioral analysis is crucial to a strong neuroscience research program because it evaluates the impact of molecular or neurochemical changes on the functioning of the entire organism. Behavioral research can be used to validate the role of a neuroscientist's specific molecular target (e.g., receptor, gene, or enzyme) in a particular behavior (e.g., emotions, learning and memory, or locomotor activity) and subsequently create whole systems that a neuroscientist can use to study a particular pathological state (e.g., depression, drug addiction or obesity). A unique strength of the MU Translational Neuroscience Center is the presence of some “bench” scientists working at the molecular level in pathology, biochemistry and genetics in collaboration with neurobehavioral experts. The Center's modern facilities and trained personnel are available to the MU neuroscience community to help design, conduct and evaluate behavioral research. This will help translate research from the molecular laboratory to the human clinic. This poster will show a summary of the different aspects and tasks we plan to perform at the MU Neurobehavioral Core Facility.